Perianal Fistula Clinical Trial
Official title:
Identification of Molecular Differences of Adipose-derived Mesenchymal Stem Cells Between Non- Responders and Responders in Treatment of Transsphincteric Perianal Fistulas Using Autologous Fat Graft Injection
This study investigated the cellular and molecular characteristics of AT-MSCs obtained from autologous AT therapy in patients with high transphincteric perianal fistulas of crytoglandular origin. Adipose tissue was injected into anal fistulas. Characteristics of adipose tissue mesenchymal stemcells (AT-MSC) was investigated and compared in patients with fistula that healed after the treatment (responders) to patients who failed to heal (non-responders)
Injection with allogene or autologous stem cells has been reported to be efficient treatment of perianal fistulas. An alternative to this treatment could be injection with freshly collected autologous adipose tissue. In this study 27 patients with cryptoglandular anal fistulas were treated with freshly collected autologous adipose tissue.A clinical assessment of the patient prior to inclusion was undertaken and a loose seton placed for at least 6 weeks prior to fat injection. An MRI of the pelvis was performed before inclusion. Fistulas with secondary tracts and/or cavities were excluded. The operation was performed in one procedure including liposuction and injection of adipose tissue. A sample of adipose tissue from all 27 patients was analyzed. AT-MSCs were isolated and characterized using cellular and molecular analyses. Clinical and MRI-scanning evaluation of fistula healing and evaluation of ano-rectal function was performed after 6 months. AT-MSCs phenotype was compared between responders and non-responders with respect to fistula healing. The evaluation of the AT-MSCs was performed in a blinded manner. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03913572 -
Treatment of Perianal Disease Using Adipose-derived Stem Cells
|
||
Terminated |
NCT01623453 -
Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)
|
N/A | |
Completed |
NCT06441526 -
Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design
|
Phase 3 | |
Recruiting |
NCT04847739 -
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
|
Phase 2 | |
Completed |
NCT06314945 -
Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula
|
||
Completed |
NCT03763981 -
Comparison of Prolene Thread Seton Vs Silk Thread Seton for the Treatment of Perianal Fistula
|
N/A | |
Not yet recruiting |
NCT05626023 -
A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT01021774 -
Anal Fistula Treatment Outcome - Collagen Plug Versus Advancement Flap Surgery
|
N/A | |
Recruiting |
NCT04519671 -
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04549311 -
Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial
|
Phase 3 | |
Completed |
NCT03555773 -
Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas
|
N/A | |
Recruiting |
NCT03707769 -
TIPS Microspheres for Perianal Fistula
|
N/A | |
Completed |
NCT03803917 -
Adipose Tissue in Crohn´s Disease Fistulas
|
N/A | |
Recruiting |
NCT03322488 -
Fistulodesis Pilot Study for Closure of Perianal Fistulae
|
N/A | |
Withdrawn |
NCT03014219 -
Phase 1 Crohn's Pediatric Sub-study of MSC AFP
|
Phase 1 | |
Completed |
NCT03209700 -
Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas
|
Phase 1 | |
Completed |
NCT03981939 -
Perianal Fistula (PAF) Validation and Burden of Illness Study
|
||
Recruiting |
NCT05721794 -
Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study
|
||
Enrolling by invitation |
NCT03861689 -
Tight Control Management in Perianal Crohn's Disease
|
N/A | |
Not yet recruiting |
NCT05709717 -
Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
|